ISPOR Publishes Report on Health Economics and Outcomes Research in Low- and Middle-Income Countries

Published May 22, 2023

LMIC Report CoverLawrenceville, NJ, USA—May 22, 2023—ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced today that it has published a new report on its work in low- and middle-income countries (LMICs). The report, “Advancing HEOR in Low- and Middle-Income Countries,” explores the distinctive needs LMICs have in developing their HEOR capacity, as well as the Society’s work to fulfill its mission to promote HEOR excellence to improve decision making for health globally in these regions.

ISPOR has a strong commitment to the advancement of HEOR in LMICs. More than 20% of the Society’s members, 65% of ISPOR regional chapters, and 35% of ISPOR student chapters are in LMICs. The report notes that LMICs face unique healthcare system challenges, “including limited resources for healthcare, gaps in human and infrastructure capacity, often fragmented systems, and growing burden of disease.”

Much of ISPOR’s work in LMICs is focused on supporting critical HEOR capacity building in these countries, through education and training. The Society also provides publishing opportunities for researchers in LMICs, chapter support, conference grants, educational funding, fee-waived membership grants, HEOR awards and more. Additional information can be found on the Society’s Advancing HEOR in Low- and Middle Income Countries webpage.


ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website  | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram 

Related Stories

Global Experts Highlight Concerns With Implementation of IRA-Mandated Medicare Drug Price Negotiation Program

Dec 5, 2023

Value in Health announced the publication of 2 new commentaries by leading experts in health economics and outcomes research, both of which raise important questions as the Centers for Medicare & Medicaid Services move forward to implement the Inflation Reduction Act’s Medicare Drug Price Negotiation Program.

Medicare Could Save an Additional $10 Billion Annually Across 10 Drugs by Using a Therapeutic Reference Pricing Approach in Upcoming Price Negotiations

Nov 7, 2023

Value in Health announced the publication of a study showing that United States Medicare could save up to an additional $5-$10 billion dollars annually across 10 drugs if it negotiated prices using a therapeutic reference pricing approach rather than using the statutory ceiling price alone.

Global Medical Device Panel Finds Little Evidence Linking Health Technology Assessment Processes to Medical Device Purchasing Decisions

Nov 6, 2023

Value in Health, the official journal of ISPOR, announced the publication of the results of a systematic literature review showing that there is sparce evidence in the health research literature to link health technology assessment processes and outcomes with device purchasing decisions
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now